首页> 外国专利> method for differentiation of the reizkolons from inflammatory bowel disease, inflammatory bowel disease (ibd) and monitoring of patients with ibd using endogenous total lactoferrin as a marker

method for differentiation of the reizkolons from inflammatory bowel disease, inflammatory bowel disease (ibd) and monitoring of patients with ibd using endogenous total lactoferrin as a marker

机译:内源性总乳铁蛋白作为标记物区分reizkolons与炎症性肠病,炎症性肠病(ibd)和监测ibd患者的方法

摘要

A method for monitoring a patient having inflammatory bowel disease, the method comprising: obtaining a first fecal sample from the inflammatory bowel disease patient at a first time; determining the concentration of endogenous lactoferrin in said first fecal sample to obtain a first lactoferrin concentration; obtaining a second fecal sample from the inflammatory bowel disease patient at a second time later than said first time; determining the concentration of endogenous lactoferrin in said second sample to obtain a second lactoferrin concentration; and comparing said first lactoferrin concentration to said second lactoferrin concentration to evaluate any differences therebetween.
机译:一种用于监测患有炎性肠病的患者的方法,该方法包括:在第一时间从炎性肠病患者获得第一粪便样品;和确定所述第一粪便样品中内源性乳铁蛋白的浓度以获得第一乳铁蛋白浓度;在比所述第一时间晚的第二时间从炎性肠病患者获得第二粪便样品;确定所述第二样品中内源性乳铁蛋白的浓度以获得第二乳铁蛋白浓度;并将所述第一乳铁蛋白浓度与所述第二乳铁蛋白浓度进行比较以评估它们之间的任何差异。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号